TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 7 | 2 | 2 | 21 | 34 | 67 | 80 | 34 |
| P | %wins | 100 | 71 | 86 | 86 | 86 | 86 | 86 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/3/15 17:07 | 1/31/15 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Hahn Timothy Jon | MD | O | SVP,Manu | P | 21 | 2.28 | 33 | 9 | 9 | 110 | D | 331 | 42 | 81 | 37 | 30 | 20 | 5 | 1 | 3 | 7 | 18 | 7 | 60 | -36 |
10/3/14 16:28 | 10/3/14 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Hahn Timothy Jon | MD | O | SVP,Manu | P | 10 | 4.05 | 12 | 3 | 3 | 101 | D | 88 | 25 | -7 | -19 | -10 | -15 | -6 | -6 | 2 | 7 | 37 | 41 | 91 | 72 |
9/26/14 17:02 | 9/25/14 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Hahn Timothy Jon | MD | O | SVP,Manu | P | 38 | 4.17 | 12 | 9 | 10 | 99 | D | 108 | 30 | -4 | -12 | -11 | -12 | -8 | -3 | 3 | -3 | 23 | 39 | 97 | 107 |
8/4/14 15:16 | 7/31/14 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Hahn Timothy Jon | MD | O | SVP,Manu | P | 21 | 2.28 | 14 | 9 | 11 | 90 | D | 95 | 59 | -22 | -1 | -15 | -5 | -6 | -5 | 3 | 2 | 14 | 32 | 81 | 184 |
2/4/14 09:26 | 1/31/14 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Hahn Timothy Jon | MD | O | SVP,Manu | P | 22 | 2.29 | 32 | 9 | 13 | 80 | D | 251 | 194 | 99 | 71 | 13 | -4 | -17 | -7 | 2 | 10 | 20 | -18 | -17 | 41 |
6/12/13 08:31 | 6/10/13 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Hahn Timothy Jon | MD | O | SVP,Manu | P | 39 | 1.88 | 3 | 21 | 42 | 71 | D | -11 | 49 | 6 | -8 | -20 | -4 | -2 | -4 | 2 | 3 | 36 | 79 | 127 | 136 |
5/16/12 14:28 | 5/14/12 | NVAX | Novavax Inc | DE | Health | BioPrd | Biological Products, (No Diag | Hahn Timothy Jon | MD | O | SVP,Manu | P | 40 | 1.33 | 1 | 30 | 150 | 50 | D | -51 | -44 | -16 | -7 | 1 | 2 | -8 | -4 | 0 | -9 | -1 | 55 | 28 | 58 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |